Allied Market Research
Loading...
0

Carrier Screening Market Expected to Reach $4.0 Billion by 2030 | CAGR 11.5%

 

Report Code : A11271

quote increase in number of patients suffering from chronic diseases fuels the growth of the global carrier screening market. quote

Sushant Terdale
Lead Analyst, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       
 

According to a new report published by Allied Market Research, titled, Carrier Screening Market by Component, Technology, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030,” the carrier screening market size was valued at $1,378.06 million in 2020, and is projected to reach $4,002.05 million by 2030, registering a CAGR of 11.5% from 2021 to 2030.

The growth of the global carrier screening market is expected to be driven primarily by increased emphasis on early disease detection and prevention, surge in demand for personalized medicine, and rise in applications of screening tests in genetic disorders. Genetic diseases, including cystic fibrosis, sickle cell anemia, and Tay–Sachs disease, are inherited disorders. For such diseases, carrier testing can provide information about a couple’s risk of having a child with a genetic condition. Many genetic disorders can be detected early during pregnancy by prenatal screening or carrier screening. Hence, increase in demand for safe and effective carrier tests is fueling the growth of this market.

The COVID-19 pandemic is an unprecedented global public health challenge, and is anticipated to have a negative impact on the carrier screening market. Pregnant or recently pregnant women with COVID-19 are more likely to be admitted to the intensive care unit or need respiratory support when compared with non-pregnant women of reproductive age. Pregnant women with COVID-19 were also more likely to give birth prematurely. For instance, as per the data published by the World Health Organization in 2020, 1 in 4 of all babies born to women with COVID-19 were admitted to a neonatal unit, but data on causes of preterm births or indications for admission to neonatal units among these babies is lacking. Stillbirth and newborn death rates however were low.

Depending on carrier screening type, the market is bifurcated into expanded carrier screening and targeted disease carrier screening. The expanded carrier screening segment is further dived into customized panel testing and predesigned panel testing. The expanded carrier screening segment was the major share contributor in 2020, owing to advancement in DNA sequencing, polymerase chain reaction, microarrays, and other technologies in the field of carrier screening. In addition, increase in cases of genetic disorder fosters the growth of the carrier screening in carrier screening market.

On the basis of carrier screening market trends by technology, the market is categorized into DNA sequencing, polymerase chain reaction, microarrays, and other technologies. The DNA sequencing segment garnered the major share of the global market in 2020, and is expected to remain dominant during the forecast period, owing to advancements in genetic analysis tools, such as assays based on next-generation sequencing & microarray technologies and molecular diagnostics.

As per end user, the market is fragmented into hospitals & clinics, reference laboratories, physician offices, and others. The hospital & clinics segment accounted for maximum market revenue in 2020, and is anticipated to maintain its dominant position during the forecast period. This is attributed to increase in cases of genetic disorders and advancements in carrier screening.

Region wise, the carrier screening market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to increase in case of pulmonary conditions, hematological conditions, neurological conditions, and other conditions, thus, rise in demand for carrier screening in such diseases are a major factor that contributes toward the growth of the market. However, Asia-Pacific is projected to register the highest growth rate from 2021 to 2030.

This report provides comprehensive competitive analysis and profiles of prominent market players such as Eurofins Scientific, Invitae Corporation, Opko Health, Fulgent Genetics Inc., Quest Diagnostics Incorporated, Natera Inc. Myriad Genetics, Illumina Inc., Thermo Fisher Scientific Inc., and Luminex Corporation.

Key Findings Of The Study

  • By type, the expanded carrier screening segment held the largest carrier screening market share in 2020, and is expected to remain dominant during the forecast period.
  • On the basis of technology, the DNA sequencing segment was the major share contributor in 2020, and is expected to maintain this trend in the coming future.
  • Depending on end user, the hospitals & clinics segment garnered the highest share in 2020, and is expected to remain dominant during the forecast period.
  • Region wise, North America is expected to experience carrier screening market growth at the highest rate, registering a CAGR of 11.0% during the forecast period.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com

 

For Media Inquiries, Please Contact

Tushar Nagose
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com

 
 

First time buyer?
Check offers and discount on this report
To get this report

 
Click Here
 
 

quote Carrier Screening Market by Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, and Others), and End User (Hospitals & Clinics, Reference Laboratories, Physician Offices, and Others)- Global Opportunity Analysis and Industry Forecast, 2021-2030 quote

View Report
 
 
Avenue Video Loading...

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 4,045 niche industries and company profiles on more than 12,953 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.

 
 

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers

 

Featured Readings

 
rep-img

Published Date Jan 2021

Surgical Equipment Market

Download Sample
rep-img

Published Date Nov 2020

Medical Implant Market

Download Sample
 

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

 
Get Industry Data Alerts
 

Buy Full Version
"Carrier Screening Market"
Purchase Enquiry